Encompass Health Corporation (EHC)

Encompass Health Corporation (EHC) is a healthcare company (medical care facilities) based in the United States. The share price is $140.61, down 1.06% on the day, which values the company at $13.8B. Price as of 17 Nov 2026, 17:16 UTC, from Yahoo Finance.

Key facts

Share price
$140.61−1.06% today
Market value
$13.8B
P/E ratio
22.5×last 12 months
Forward P/E
20.4×
Dividend yield
0.55%
Funk Score
58/100
Against its own history
Well above its usual priceusual price $97.00
200-week average
$93.4850% above

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Encompass Health Corporation in more detail

EHC trades at 22.5× its last twelve months' earnings, 20.4× next year's expected earnings, 2.2× sales. Measured against its own history, the price is 45% above what its usual multiples would imply ($97.00) — well above its usual price. It sits 50% above its 200-week average of $93.48.

Over the last five fiscal years Encompass Health Corporation has compounded revenue 10.7% a year, earnings per share 14.2% a year, free cash flow 7.1% a year. Its Funk Score is 58 out of 100 (financial strength 6.1, profitability 6.8, growth 6.6, value 3.9, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score.

4 of the superinvestors tracked here hold EHC, including Brandon Haley (0.2% of the portfolio), Fred DiSanto (0.2% of the portfolio), Ken Griffin (0.1% of the portfolio).

Superinvestors holding EHC

4 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:EHC vs BTSG (Encompass Health Corporation vs BrightSpring Health Services)EHC vs BAX (Encompass Health Corporation vs Baxter International)EHC vs ELAN (Encompass Health Corporation vs Elanco Animal Health)EHC vs GKOS (Encompass Health Corporation vs Glaukos)EHC vs SNN (Encompass Health Corporation vs Smith & Nephew)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Encompass Health Corporation (EHC): questions and answers

What is EHC's P/E ratio?

Encompass Health Corporation trades at 22.5× its last twelve months' earnings and 20.4× next year's expected earnings. At its fiscal year-ends over the past 18 years the P/E ranged from 2.5× to 24.4×, with a median of 17.8×.

What is EHC's PEG ratio?

Encompass Health Corporation's PEG ratio is 0.41 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Encompass Health Corporation's market cap?

Encompass Health Corporation is valued at $13.8B at a share price of $140.61.

Is EHC overvalued or undervalued?

Against its own history, EHC is well above its usual price: the price is 45% above the $97.00 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is EHC above its 200-week moving average?

Yes. EHC is 50.4% above its 200-week average of $93.48. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Encompass Health Corporation growing?

Over the last five fiscal years Encompass Health Corporation's revenue grew 10.7% a year and its earnings per share 14.2% a year.

Cite this page

Funkfolio, “Encompass Health Corporation (EHC) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/EHC

Underlying data: Yahoo Finance; company filings with the SEC.